Profitability
Weight: 20%
B-
63
- 5yr Avg ROIC 19.4%
- Operating Margin Trend -6.65 pp/yr
IRWD
Ironwood Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
Capital Efficiency
Weight: 15%
B+
76
- 5yr Avg ROE 57.0%
- 5yr Share-Count CAGR 2.0%
Growth Quality
Weight: 15%
F
12
- 5yr Revenue CAGR -5.3%
- 5yr EPS CAGR -25.6%
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 15%
A-
84
- 5yr FCF Margin 48.7%
- 5yr FCF/NI Conversion 31.21x
Balance Sheet
Weight: 20%
D-
30
- Net Debt / EBITDA 3.65x
- Interest Coverage (EBIT/Int) 3.14x
- Altman Z-Score -3.57
Stability
Weight: 15%
D-
30
- EPS Volatility (σ/μ) 1.30
- Negative-Revenue Years (5) 3/5
- Piotroski F-Score 6
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.1 of 2 gurus held; 1 added; 1 full exit.
- Holders
- 1 -1
- Avg Δ position
- +156.4%
- New buys
- 0
- Full exits
- 1
- Greenblatt sold -100%
- Cooperman increased +156%